GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
2.290
-0.030 (-1.29%)
At close: Dec 20, 2024, 4:00 PM
2.271
-0.019 (-0.85%)
After-hours: Dec 20, 2024, 7:24 PM EST
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $21.61 million as of December 20, 2024. Its market cap has increased by 108.89% in one year.
Market Cap
21.61M
Enterprise Value
13.02M
1-Year Change
108.89%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since May 13, 2019, GeoVax Labs's market cap has increased from $1.04M to $21.61M, an increase of 1,969.83%. That is a compound annual growth rate of 71.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 21.61M | 124.23% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.01% |
| Dec 31, 2020 | 12.03M | 6,734.40% |
| Dec 31, 2019 | 176.04K | -83.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences | 21.68M |
| NanoViricides | 21.66M |
| Bionano Genomics | 21.43M |
| BioLineRx | 21.33M |
| IN8bio | 21.32M |
| Cadrenal Therapeutics | 20.62M |
| Citius Pharmaceuticals | 20.53M |
| Carisma Therapeutics | 20.50M |